2023
DOI: 10.1038/s41523-023-00530-5
|View full text |Cite
|
Sign up to set email alerts
|

Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence

Abstract: Gene expression-based recurrence assays are strongly recommended to guide the use of chemotherapy in hormone receptor-positive, HER2-negative breast cancer, but such testing is expensive, can contribute to delays in care, and may not be available in low-resource settings. Here, we describe the training and independent validation of a deep learning model that predicts recurrence assay result and risk of recurrence using both digital histology and clinical risk factors. We demonstrate that this approach outperfo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(10 citation statements)
references
References 38 publications
(41 reference statements)
0
10
0
Order By: Relevance
“…According to previous studies, clinical nomograms have been applied to breast diseases in numerous aspects, such as predicting breast cancer, assessing the diagnostic performance of imaging methods in breast diseases ( 18 21 ), predicting axillary lymph node metastasis of breast cancer ( 22 ), and predicting the recurrence rate and risk of breast cancer ( 23 ), etc. In the ultrasonic differentiation between SA and malignant tumors, the findings of Liang’s study were consistent with ours ( 17 ).…”
Section: Discussionmentioning
confidence: 99%
“…According to previous studies, clinical nomograms have been applied to breast diseases in numerous aspects, such as predicting breast cancer, assessing the diagnostic performance of imaging methods in breast diseases ( 18 21 ), predicting axillary lymph node metastasis of breast cancer ( 22 ), and predicting the recurrence rate and risk of breast cancer ( 23 ), etc. In the ultrasonic differentiation between SA and malignant tumors, the findings of Liang’s study were consistent with ours ( 17 ).…”
Section: Discussionmentioning
confidence: 99%
“…We trained deep learning classification models based on an Xception architecture, using ImageNet pretrained weights and two hidden layers of width 1024, with dropout ( p = 0.1) after each hidden layer. Xception was chosen out of prior experience due to its fast convergence and high performance for histopathological applications 43 , 51 54 . Models were trained with Slideflow using the Tensorflow backend with a single set of hyperparameters and category-level mini-batch balancing (Supplementary Table 3 ).…”
Section: Methodsmentioning
confidence: 99%
“…AI algorithms could not only detect and diagnose cancer cells but also predict the clinical outcome of patients based on the histopathology of various types of cancers [ 63 64 65 66 ]. Huang et al [ 30 ] recently developed a DL algorithm for the prognostic prediction of GC using 2,333 H&E images from real-world datasets and The Cancer Genome Atlas (TCGA) program data.…”
Section: Prediction Of the Clinical Outcome And Biomarker Detectionmentioning
confidence: 99%